ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OPGN OpGen Inc

2.24
0.01 (0.45%)
10 Aug 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
OpGen Inc NASDAQ:OPGN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 0.45% 2.24 1.65 3.96 2.365 2.23 2.28 3,810 01:00:00

OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call

02/08/2016 1:30pm

GlobeNewswire Inc.


OpGen (NASDAQ:OPGN)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more OpGen Charts.

OpGen, Inc. (NASDAQ:OPGN) today announced that financial results for the company’s second quarter ended June 30, 2016 will be released Tuesday, August 9, 2016. The management team will host a conference call discussing the company’s financial results and recent developments that day at 4:30 p.m. E.T.

The call may be accessed by dialing (888) 883-4599 (domestic) or (484) 653-6821 (international) five minutes prior to the start of the call and providing passcode 54852842.

The live, listen-only webcast of the conference call may be accessed by visiting the investors section of the company’s website at http://ir.opgen.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company’s website.

A telephone replay also will be available from 7:30 p.m. E.T. through August 15, 2016 and may be accessed by dialing (855) 859-2056 from within the U.S. or (404) 537-3406 from outside the U.S. All listeners should provide passcode 54852842.

About OpGenOpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.

Contacts:

OpGen
Michael Farmer
Director, Marketing
(240) 813-1284 
mfarmer@opgen.com
InvestorRelations@opgen.com
            
Investor Relations
LHA
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
or
Bruce Voss
(310) 691-7100
bvoss@lhai.com

OpGen Media 
MacDougall Biomedical Communications 
Cammy Duong
781-235-3060
cduong@macbiocom.com

1 Year OpGen Chart

1 Year OpGen Chart

1 Month OpGen Chart

1 Month OpGen Chart

Your Recent History

Delayed Upgrade Clock